OHB NEONATOLOGY LTD
Get an alert when OHB NEONATOLOGY LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-01-17 (in 8mo)
Last made up 2026-01-03
Watchouts
None on the register
Cash
£3K
+998.8% vs 2023
Net assets
£32M
+7.4% vs 2023
Employees
0
Average over period
Profit before tax
£2M
-63.3% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £40,633,180 | £17,382,259 | |
| Operating profit | £34,589,804 | £1,799,632 | |
| Profit before tax | £4,899,122 | £1,799,632 | |
| Net profit | £2,393,620 | £2,219,032 | |
| Cash | £245 | £2,692 | |
| Total assets less current liabilities | £33,011,183 | £35,230,215 | |
| Net assets | £30,046,024 | £32,265,056 | |
| Equity | £30,046,024 | £32,265,056 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 85.1% | 10.4% | |
| Net margin | 5.9% | 12.8% | |
| Return on capital employed | 104.8% | 5.1% | |
| Gearing (liabilities / total assets) | 32.9% | 30.5% | |
| Current ratio | 3.80x | 4.15x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102 §1A
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Frazier & Deeter (UK Audit) LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future.”
Significant events
- “In November 2023 the Company entered into a License and Development Agreement with Chiesi Farmaceutici S.p.A ("Chiesi") to develop, manufacture, and commercialize OHB-607.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 0 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| OAKWOOD CORPORATE SECRETARY LIMITED | Corporate Secretary | 2022-01-04 | — | — |
| DISTLER, Josh | Director | 2022-01-04 | Jul 1975 | American |
| MCHALE, Mark | Director | 2022-01-04 | Feb 1965 | British |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Oak Hill Bio Ltd | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2022-01-04 | Active |
Filing timeline
Last 10 of 10 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-02 | AA | accounts | Accounts with accounts type full | |
| 2025-01-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-12-05 | AA | accounts | Accounts with accounts type full | |
| 2024-01-16 | SH01 | capital | Capital allotment shares | |
| 2024-01-12 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-10-27 | AA | accounts | Accounts with accounts type total exemption full | |
| 2023-01-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-01-19 | AA01 | accounts | Change account reference date company current shortened | |
| 2022-01-04 | NEWINC | incorporation | Incorporation company |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-57.2%
£40,633,180 £17,382,259
-
Cash
+998.8%
£245 £2,692
-
Net assets
+7.4%
£30,046,024 £32,265,056
-
Employees
—
Not reported
-
Operating profit
-94.8%
£34,589,804 £1,799,632
-
Profit before tax
-63.3%
£4,899,122 £1,799,632
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers